BACKGROUND AND PURPOSE: To evaluate whether increased neuroimaging use is associated with increased brain arteriovenous malformation (BAVM) detection, we examined detection rates in the Kaiser Permanente Medical Care Program of northern California between 1995 and 2004. METHODS: We reviewed medical records, radiology reports, and administrative databases to identify BAVMs, intracranial aneurysms (IAs: subarachnoid hemorrhage [SAH] and unruptured aneurysms), and other vascular malformations (OVMs: dural fistulas, cavernous malformations, Vein of Galen malformations, and venous malformations). Poisson regression (with robust standard errors) was used to test for trend. Random-effects meta-analysis generated a pooled measure of BAVM detection rate from 6 studies. RESULTS: We identified 401 BAVMs (197 ruptured, 204 unruptured), 570 OVMs, and 2892 IAs (2079 SAHs and 813 unruptured IAs). Detection rates per 100 000 person-years were 1.4 (95% CI, 1.3 to 1.6) for BAVMs, 2.0 (95% CI, 1.8 to 2.3) for OVMs, and 10.3 (95% CI, 9.9 to 10.7) for IAs. Neuroimaging utilization increased 12% per year during the time period (P<0.001). Overall, rates increased for IAs (P<0.001), remained stable for OVMs (P=0.858), and decreased for BAVMs (P=0.001). Detection rates increased 15% per year for unruptured IAs (P<0.001), with no change in SAHs (P=0.903). However, rates decreased 7% per year for unruptured BAVMs (P=0.016) and 3% per year for ruptured BAVMs (P=0.005). Meta-analysis yielded a pooled BAVM detection rate of 1.3 (95% CI, 1.2 to 1.4) per 100 000 person-years, without heterogeneity between studies (P=0.25). CONCLUSIONS: Rates for BAVMs, OVMs, and IAs in this large, multiethnic population were similar to those in other series. During 1995 to 2004, a period of increasing neuroimaging utilization, we did not observe an increased rate of detection of unruptured BAVMs, despite increased detection of unruptured IAs.
BACKGROUND AND PURPOSE: To evaluate whether increased neuroimaging use is associated with increased brain arteriovenous malformation (BAVM) detection, we examined detection rates in the Kaiser Permanente Medical Care Program of northern California between 1995 and 2004. METHODS: We reviewed medical records, radiology reports, and administrative databases to identify BAVMs, intracranial aneurysms (IAs: subarachnoid hemorrhage [SAH] and unruptured aneurysms), and other vascular malformations (OVMs: dural fistulas, cavernous malformations, Vein of Galen malformations, and venous malformations). Poisson regression (with robust standard errors) was used to test for trend. Random-effects meta-analysis generated a pooled measure of BAVM detection rate from 6 studies. RESULTS: We identified 401 BAVMs (197 ruptured, 204 unruptured), 570 OVMs, and 2892 IAs (2079 SAHs and 813 unruptured IAs). Detection rates per 100 000 person-years were 1.4 (95% CI, 1.3 to 1.6) for BAVMs, 2.0 (95% CI, 1.8 to 2.3) for OVMs, and 10.3 (95% CI, 9.9 to 10.7) for IAs. Neuroimaging utilization increased 12% per year during the time period (P<0.001). Overall, rates increased for IAs (P<0.001), remained stable for OVMs (P=0.858), and decreased for BAVMs (P=0.001). Detection rates increased 15% per year for unruptured IAs (P<0.001), with no change in SAHs (P=0.903). However, rates decreased 7% per year for unruptured BAVMs (P=0.016) and 3% per year for ruptured BAVMs (P=0.005). Meta-analysis yielded a pooled BAVM detection rate of 1.3 (95% CI, 1.2 to 1.4) per 100 000 person-years, without heterogeneity between studies (P=0.25). CONCLUSIONS: Rates for BAVMs, OVMs, and IAs in this large, multiethnic population were similar to those in other series. During 1995 to 2004, a period of increasing neuroimaging utilization, we did not observe an increased rate of detection of unruptured BAVMs, despite increased detection of unruptured IAs.
Authors: C Hofmeister; C Stapf; A Hartmann; R R Sciacca; U Mansmann; K terBrugge; P Lasjaunias; J P Mohr; H Mast; J Meisel Journal: Stroke Date: 2000-06 Impact factor: 7.914
Authors: Christian Stapf; Daniel L Labovitz; Robert R Sciacca; Henning Mast; Jay P Mohr; Ralph L Sacco Journal: Cerebrovasc Dis Date: 2002 Impact factor: 2.762
Authors: Rustam Al-Shahi; Jo J Bhattacharya; David G Currie; Vakis Papanastassiou; Vaughn Ritchie; Richard C Roberts; Robin J Sellar; Charles P Warlow Journal: Stroke Date: 2003-04-17 Impact factor: 7.914
Authors: C Stapf; H Mast; R R Sciacca; A Berenstein; P K Nelson; Y P Gobin; J Pile-Spellman; J P Mohr Journal: Stroke Date: 2003-04-10 Impact factor: 7.914
Authors: Helen Kim; Pirro G Hysi; Ludmila Pawlikowska; Shweta Choudhry; Esteban González Burchard; Pui-Yan Kwok; Stephen Sidney; Charles E McCulloch; William L Young Journal: Neuroepidemiology Date: 2008-10-07 Impact factor: 3.282
Authors: Alexander X Halim; S Claiborne Johnston; Vineeta Singh; Charles E McCulloch; John P Bennett; Achal S Achrol; Stephen Sidney; William L Young Journal: Stroke Date: 2004-05-27 Impact factor: 7.914
Authors: Felicitas J Detmer; Bong Jae Chung; Fernando Mut; Martin Slawski; Farid Hamzei-Sichani; Christopher Putman; Carlos Jiménez; Juan R Cebral Journal: Int J Comput Assist Radiol Surg Date: 2018-08-09 Impact factor: 2.924
Authors: Felicitas J Detmer; Daniel Lückehe; Fernando Mut; Martin Slawski; Sven Hirsch; Philippe Bijlenga; Gabriele von Voigt; Juan R Cebral Journal: Int J Comput Assist Radiol Surg Date: 2019-09-04 Impact factor: 2.924
Authors: Felicitas J Detmer; Bong Jae Chung; Carlos Jimenez; Farid Hamzei-Sichani; David Kallmes; Christopher Putman; Juan R Cebral Journal: Neuroradiology Date: 2018-11-19 Impact factor: 2.804